Fingerprint
Dive into the research topics of 'Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically